Matches in Nanopublications for { ?s ?p "[In addition, this gene may be responsible for a new hereditary syndrome predisposing to a variety of tumors designated `rhabdoid predisposition syndrome.` In the present study, we analyzed a series of 53 ependymal tumors of 48 patients [4 myxopapillary ependymomas (WHO grade I), 3 subependymomas (WHO grade I), 18 ependymomas (WHO grade II), 21 anaplastic ependymomas (WHO grade III) and 2 ependymoblastomas (WHO grade IV)] for mutations and homozygous deletions in the coding region of the hSNF5/INI1 gene and for allelic loss of its flanking chromosomal regions in 39 ependymal tumors of 35 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP633467.RAR_OFxUTPm9Stp5v-T_OadGA9RTwUbRBh4_Q8P3mAciM130_assertion description "[In addition, this gene may be responsible for a new hereditary syndrome predisposing to a variety of tumors designated `rhabdoid predisposition syndrome.` In the present study, we analyzed a series of 53 ependymal tumors of 48 patients [4 myxopapillary ependymomas (WHO grade I), 3 subependymomas (WHO grade I), 18 ependymomas (WHO grade II), 21 anaplastic ependymomas (WHO grade III) and 2 ependymoblastomas (WHO grade IV)] for mutations and homozygous deletions in the coding region of the hSNF5/INI1 gene and for allelic loss of its flanking chromosomal regions in 39 ependymal tumors of 35 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633467.RAR_OFxUTPm9Stp5v-T_OadGA9RTwUbRBh4_Q8P3mAciM130_provenance.
- NP780959.RAAX8RrQ8S4deLZtagIZnSjkjyjYoo9d9s23LfJnlSPgg130_assertion description "[In addition, this gene may be responsible for a new hereditary syndrome predisposing to a variety of tumors designated `rhabdoid predisposition syndrome.` In the present study, we analyzed a series of 53 ependymal tumors of 48 patients [4 myxopapillary ependymomas (WHO grade I), 3 subependymomas (WHO grade I), 18 ependymomas (WHO grade II), 21 anaplastic ependymomas (WHO grade III) and 2 ependymoblastomas (WHO grade IV)] for mutations and homozygous deletions in the coding region of the hSNF5/INI1 gene and for allelic loss of its flanking chromosomal regions in 39 ependymal tumors of 35 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780959.RAAX8RrQ8S4deLZtagIZnSjkjyjYoo9d9s23LfJnlSPgg130_provenance.
- NP435594.RAXTaIDJAPGRQZvPePztY2vTOdFMY6nNJeoHb9l9fmjRQ130_assertion description "[In addition, this gene may be responsible for a new hereditary syndrome predisposing to a variety of tumors designated `rhabdoid predisposition syndrome.` In the present study, we analyzed a series of 53 ependymal tumors of 48 patients [4 myxopapillary ependymomas (WHO grade I), 3 subependymomas (WHO grade I), 18 ependymomas (WHO grade II), 21 anaplastic ependymomas (WHO grade III) and 2 ependymoblastomas (WHO grade IV)] for mutations and homozygous deletions in the coding region of the hSNF5/INI1 gene and for allelic loss of its flanking chromosomal regions in 39 ependymal tumors of 35 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435594.RAXTaIDJAPGRQZvPePztY2vTOdFMY6nNJeoHb9l9fmjRQ130_provenance.
- NP721033.RAfIze5mr2IgDwNdAJ-L6OdRtvF-QzPiDlYCHTBOvE14o130_assertion description "[In addition, this gene may be responsible for a new hereditary syndrome predisposing to a variety of tumors designated `rhabdoid predisposition syndrome.` In the present study, we analyzed a series of 53 ependymal tumors of 48 patients [4 myxopapillary ependymomas (WHO grade I), 3 subependymomas (WHO grade I), 18 ependymomas (WHO grade II), 21 anaplastic ependymomas (WHO grade III) and 2 ependymoblastomas (WHO grade IV)] for mutations and homozygous deletions in the coding region of the hSNF5/INI1 gene and for allelic loss of its flanking chromosomal regions in 39 ependymal tumors of 35 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721033.RAfIze5mr2IgDwNdAJ-L6OdRtvF-QzPiDlYCHTBOvE14o130_provenance.
- NP615438.RA6rQFOSsRUtQKjqsSe0dyIHpkqi3CIfKKGNLH6ZSdbwM130_assertion description "[In addition, this gene may be responsible for a new hereditary syndrome predisposing to a variety of tumors designated `rhabdoid predisposition syndrome.` In the present study, we analyzed a series of 53 ependymal tumors of 48 patients [4 myxopapillary ependymomas (WHO grade I), 3 subependymomas (WHO grade I), 18 ependymomas (WHO grade II), 21 anaplastic ependymomas (WHO grade III) and 2 ependymoblastomas (WHO grade IV)] for mutations and homozygous deletions in the coding region of the hSNF5/INI1 gene and for allelic loss of its flanking chromosomal regions in 39 ependymal tumors of 35 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615438.RA6rQFOSsRUtQKjqsSe0dyIHpkqi3CIfKKGNLH6ZSdbwM130_provenance.
- NP806989.RA2Y4ScJXsL-aUFT-xGTZy49oGaJm_LfxBKOjC13ez8ds130_assertion description "[In addition, this gene may be responsible for a new hereditary syndrome predisposing to a variety of tumors designated `rhabdoid predisposition syndrome.` In the present study, we analyzed a series of 53 ependymal tumors of 48 patients [4 myxopapillary ependymomas (WHO grade I), 3 subependymomas (WHO grade I), 18 ependymomas (WHO grade II), 21 anaplastic ependymomas (WHO grade III) and 2 ependymoblastomas (WHO grade IV)] for mutations and homozygous deletions in the coding region of the hSNF5/INI1 gene and for allelic loss of its flanking chromosomal regions in 39 ependymal tumors of 35 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806989.RA2Y4ScJXsL-aUFT-xGTZy49oGaJm_LfxBKOjC13ez8ds130_provenance.